http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1003727-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5731aa4881af0699108372a8a9e1e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-22 |
| filingDate | 1998-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5daf3cef7e6e130d73e70fa9ef81d352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0f0d8e9c81e062daf1802f8baa23029 |
| publicationDate | 2000-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1003727-A1 |
| titleOfInvention | Antibiotic for methicillin resistant bacteria |
| abstract | The present invention is directed to anti-bacterial and anti-tumor agents and the synthesis thereof. |
| priorityDate | 1997-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.